菲律宾ETF-iShares EPHE 深 沪
等待开盘 05-20 09:30:00 美东时间
24.20
-0.340
-1.39%
华盛通- 最 高24.45
- 今 开24.24
- 成交量 8.54万股
- 最 低 24.20
- 昨 收 24.54
- 总市值 1.29亿
- 52周最高 28.40
- 市盈率 静 --
- 换手率 1.60%
- 52周最低 22.9706
- 委 比 0.00%
- 总股本 535.00万
- 历史最高 39.3143
- 量 比 1.04
- 振 幅 1.02%
- 历史最低 16.3524
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Stephen Smith And Smith Financial Corporation Acquire Minority Stake In The Economist Group
BRIEF-Stephen Smith And Smith Financial Corporation Acquire Minority Stake In The Economist Group April 24 (Reuters) - THE ECONOMIST GROUP: STEPHEN SMITH AND SMITH FINANCIAL CORPORATION ACQUIRE MINORITY STAKE IN THE ECONOMIST GROUP THE ECONOMIST GROUP: FINANCIAL TERMS OF TRANSACTION HAVE NOT BEEN DI
04-24 17:46
Reported April 11: Philippines Orders Meta Platforms To Curb Spread Of False Content On Platform
https://pco.gov.ph/news_releases/govt-orders-meta-platforms-inc-to-curb-all-fake-news-warns-of-legal-action/
04-13 21:49
BRIEF-American Express Chairman And CEO Stephen J. Squeri Highlights The Company’S 2025 Performance And Position Of Strength In An Ai-Powered World In Letter To Shareholders
BRIEF-American Express Chairman And CEO Stephen J. Squeri Highlights The Company’S 2025 Performance And Position Of Strength In An Ai-Powered World In Letter To Shareholders American Express Co AXP.N : AMERICAN EXPRESS CHAIRMAN AND CEO STEPHEN J. SQUERI HIGHLIGHTS THE COMPANY’S 2025 PERFORMANCE AND
03-25 20:30
BRIEF-Unitedhealth - Amends Stock Option For Stephen Hemsley - SEC Filing
BRIEF-Unitedhealth - Amends Stock Option For Stephen Hemsley - SEC Filing Feb 25 (Reuters) - UnitedHealth Group Inc UNH.N : UNITEDHEALTH - AMENDS STOCK OPTION FOR STEPHEN HEMSLEY - SEC FILING UNITEDHEALTH - AMENDMENT ADDS TWO-YEAR SHARE HOLDING REQUIREMENT UNTIL MAY 2030 - SEC FILING Source text: []
02-25 19:25
BRIEF-RCL Says Samuel Minzberg To Become Board Chair
BRIEF-RCL Says Samuel Minzberg To Become Board Chair Feb 19 (Reuters) - Reitmans Canada Ltd RETa.V : RCL ANNOUNCES BOARD LEADERSHIP TRANSITION REITMANS CANADA LTD - STEPHEN REITMAN TRANSITIONS TO BOARD DIRECTOR AND CHAIRMAN EMERITUS REITMANS CANADA LTD: SAMUEL MINZBERG TO BECOME BOARD CHAIR Source t
02-20 06:55
BRIEF-Nektar Therapeutics Announces Research Collaboration With Ucsf And Dr. Stephen Hauser For Nktr-0165
BRIEF-Nektar Therapeutics Announces Research Collaboration With Ucsf And Dr. Stephen Hauser For Nktr-0165 Feb 17 (Reuters) - Nektar Therapeutics NKTR.O : NEKTAR THERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH UCSF AND DR. STEPHEN HAUSER FOR NKTR-0165, A TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) AN
02-17 20:27
BRIEF-Av Welcomes Stephen Voline As Senior Director, Washington Operations
BRIEF-Av Welcomes Stephen Voline As Senior Director, Washington Operations Feb 11 (Reuters) - AeroVironment Inc AVAV.O : AV WELCOMES STEPHEN VOLINE AS SENIOR DIRECTOR, WASHINGTON OPERATIONS Source text: ID:nBwRqZ41a Further company coverage: AVAV.O (( Reuters.Briefs@thomsonreuters.com ;))
02-11 20:45
BRIEF-Matthew J Saker Appointed Interim CEO Of Aureus Greenway
BRIEF-Matthew J Saker Appointed Interim CEO Of Aureus Greenway Feb 3 (Reuters) - Aureus Greenway Holdings Inc AGH.O : AUREUS GREENWAY HOLDINGS INC - ON JAN 28, CHIPING CHEUNG RESIGNS AS CEO, PRESIDENT, AND DIRECTOR - SEC FILING AUREUS GREENWAY HOLDINGS INC - MATTHEW J. SAKER APPOINTED INTERIM CEO -
02-04 00:04
FDA Approves Johnson & Johnson's DARZALEX FASPRO Regimen for Newly Diagnosed Multiple Myeloma
FDA Approves Johnson & Johnson's DARZALEX FASPRO Regimen for Newly Diagnosed Multiple Myeloma The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for
01-28 04:49
BRIEF-Customers Bank Appoints Stephen Wyremski As Chief Operating Officer
BRIEF-Customers Bank Appoints Stephen Wyremski As Chief Operating Officer Jan 26 (Reuters) - Customers Bancorp Inc CUBI.N : CUSTOMERS BANK APPOINTS STEPHEN WYREMSKI AS CHIEF OPERATING OFFICER Source text: ID:nBw7LZsMsa Further company coverage: CUBI.N (( Reuters.Briefs@thomsonreuters.com ;))
01-27 06:40
